Related Experiment Video
Updated: Jul 2, 2026

05:26
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
Salivary Extracellular Vesicles: Paradigm Shift in Liquid Biopsy Diagnostics
Kwanele Xulu1,2, Usri H Ibrahim2, Irene Mackraj1
1Department of Human Physiology School of Laboratory Medicine and Medical Sciences University of KwaZulu-Natal Durban South Africa.
Journal of Extracellular Biology
|July 1, 2026
Summary
Salivary extracellular vesicles (EVs) are promising biomarkers for diagnosing diseases. This review highlights their potential, challenges, and clinical translation prospects for minimally invasive liquid biopsies.
Area of Science:
- Biochemistry
- Cell Biology
- Biomarkers
Background:
- Extracellular vesicles (EVs) are key intercellular communicators.
- EVs are implicated in various pathophysiological processes.
- EVs show potential as diagnostic and prognostic biomarkers.
Purpose of the Study:
- To review the current landscape of salivary EVs.
- To highlight their unique characteristics and diagnostic potential.
- To discuss challenges and future prospects for clinical translation.
Main Methods:
- Literature review of salivary EV research.
- Analysis of EV characteristics and diagnostic applications.
- Discussion of technical challenges and clinical translation.
Main Results:
- Saliva is an accessible biofluid with a low protein content, ideal for EV isolation.
- Salivary EVs show promise for diagnosing cancers, autoimmune diseases, and neuropsychiatric disorders.
- Technical challenges exist but are being addressed for clinical use.
Conclusions:
- Salivary EVs represent a powerful, minimally invasive tool for disease diagnosis.
- Further research and technological advancements are needed for widespread clinical adoption.
- EVs in saliva offer a promising avenue for liquid biopsy-based diagnostics.

